The Newsflashes bring you up to date with the SUMMIT most recent development
News & Events
4th SUMMIT Newsletter!
This issue highlights the forthcoming EASD meeting and the 1-st joint satellite symposium of IMI Diabetes Platform, both to be held in Barcelona September 23-27. It also provides an overview of the most recent findings more...
Enjoy the read of the 4th Issue of our newsletter!
SUMMIT presents at EASD!
Several members of SUMMIT have officially been selected to present SUMMIT research findings at the 49th Annual Diabetes EASD Meeting, to be held September 23-27 at the Fira Gran Via exhibition Centre in Barcelona, Spain. In addition, the SUMMIT experts Prof. Leif Groop of Lund University, Prof. Pirjo Nuutila of University of Turku, and Prof. Ele Ferrannini of University of Pisa have been invited as keynote speakers.
For the programme click here.
SUMMIT announces the first joint symposium of the IMI diabetes Platform!
On the occassion of 49th EASD Annual Meeting, SUMMIT announces the first joint symposium of the IMI Diabetes Platform: "Opening a new chapter in diabetes research: recent results from the IMI diabetes consortia SUMMIT, IMIDIA & DIRECT" more...
For the programme click here.
19.06. 2013 - 05.07.2013
The SUMMIT partner University of Pisa organizes the Summer school "Advances in Cardiovascular Medicine".
The objective is to provide an up-to-date intensive course on “hot topics” in cardiovascular medicine, covering Epidemiology, Risk assessment and Prevention, Major clinical problems, Imaging, Therapy, Lifestyle and Cardiovascular System, Cardiovascular adaptation to extreme conditions more...
Click here for the announcement and programme.
27.02 - 28.02. 2013
The SUMMIT Coordinator
Boehringer-Ingelheim hosted the fourth SUMMIT annual meeting.
The meeting venue was held at the BI R&D campus in Biberach an der Riss and at the Maritim Hotel in Ulm. The meeting had inter-Work Package discussions on each disease indication as focus point more...
22.04.2015: save the date!
A leap forward for diabetes complications
On the occasion of the final SUMMIT Plenary meeting 2015 we warmly welcome anyone with an interest in diabetes complications research to our open symposium hosted by Lund University Diabetes Centre in Malmö,
on April 22, 2015.
SUMMIT investigators will present and discuss highlights form the SUMMIT research, with invited speakers adding the wider perspective to the importance of our achievements.
For information on venue, registration and the programme, please click here.
To DISCOVER, DEVELOP and QUALIFY potential MARKERS that empower:
the identification of patients at high risk of diabetes complications
the monitoring of the complications' progression and patients‘ response to therapy
To use the discovered markers as SURROGATE ENDPOINTS in clinical trials.
Thereby, SHORTEN the long lasting CLINICAL TRIALS to bring about EARLIER availability of NEW THERAPY to diabetic patients.